Think Bioscience is reimagining synthetic biology by using living systems to guide the design and assembly of better medicines. The unique approach to drug discovery combines applied microbiology, enzymology, and computational science to develop small-molecule therapeutics against elusive targets.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/19/22 | $17,000,000 | Seed |
AV8 Ventures Axial VC Buff Gold Ventures Innovation Endeavors  LiquidMetal Ventures Wireframe Ventures Xora Innovation | undisclosed |
| 05/07/24 | $6,000,000 | Seed Extension |
YK Bioventures | undisclosed |
| 01/20/26 | $55,000,000 | Series A |
AV8 Ventures Buff Gold Ventures CE-Ventures CU Innovations Innovation Endeavors Janus Henderson Investors MBX Capital Regeneron Ventures T.A. Springer YK Bioventures | undisclosed |
